Cognitive behavioural interventions for depression in chronic neurological conditions: A systematic review

Journal of Psychosomatic Research

Volumn 78, Issue 5, 2015, Pages 411-419

  Fernie, Bruce A ^a,b   Kollmann, Josianne ^a,c   Brown, Richard G ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Alzheimer's disease; CBT; Depression; Epilepsy; Multiple sclerosis; Parkinson's disease

Indexed keywords

ALZHEIMER DISEASE; ANXIETY DISORDER; CHRONIC DISEASE; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; EPILEPSY; HUMAN; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; REVIEW; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; ANXIETY; COMPLICATION; FEMALE; MENTAL HEALTH; PROCEDURES; PSYCHOLOGICAL RATING SCALE; SENSITIVITY AND SPECIFICITY;

ANXIETY; CHRONIC DISEASE; COGNITIVE THERAPY; DEPRESSION; FEMALE; HUMANS; MENTAL HEALTH; NERVOUS SYSTEM DISEASES; PSYCHIATRIC STATUS RATING SCALES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84925869516     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2015.02.012     Document Type: Review

References (43)

1. von Campenhausen S, Bornschein B, Wick R, Bötzel K, Sampaio C, Poewe W, et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 2005, 15(4):473-490.
2. Berr C, Wancata J, Ritchie K Prevalence of dementia in the elderly in Europe. Eur Neuropsychopharmacol 2005, 15(4):463-471.
3. Forsgren L, Beghi E, Õun A, Sillanpää M The epidemiology of epilepsy in Europe - a systematic review. Eur J Neurol 2005, 12(4):245-253.
4. Poser CM The epidemiology of multiple sclerosis: A general overview. Ann Neurol 1994, 36(S2):S180-S193.
5. Rosati G The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001, 22(2):117-139.
6. Naylor C, Parsonage M, McDaid D, Knapp M, Fossey M, Galea A Long-term conditions and mental health. The cost of co-morbidities 2012, The King's Fund and Centre for, Mental Health.
7. Reijnders JSAM, Ehrt U, Weber WEJ, Aarsland D, Leentjens AFG A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008, 23:183-189.
8. Menza MA, Robertson-Hoffman DE, Bonapace AS Parkinson's disease and anxiety: comorbidity with depression. Biol Psychiatry 1993, 34(7):465-470.
9. Siegert RJ, Abernethy DA Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 2005, 76(4):469-475.
10. Ballard C, Neill D, O'Brien J, McKeith IG, Ince P, Perry R Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord 2000, 59(2):97-106.
11. Vuilleumier P, Jallon P Epilepsy and psychiatric disorders: epidemiological data. Rev Neurol 1998, 154(4):305-317.
12. Tsopelas ND, Saintfort R, Fricchione GL The relationship of psychiatric illnesses and seizures. Curr Psychiatry Rep 2001, 3:235-242.
13. Starkstein SE, Merello M Psychiatric and cognitive disorders in Parkinson's disease 2002, Cambridge University Press, Cambridge, [200 pp.].
14. Armstrong MJ, Gruber-Baldini AL, Reich SG, Fishman PS, Lachner C, Shulman LM Which features of Parkinson's disease predict earlier exit from the workforce?. Parkinsonism Relat Disord 2014, 20:1257-1259.
15. Duncan GW, Khoo TK, Yarnall AJ, O'Brien JT, Coleman SY, Brooks DJ, et al. Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms. Mov Disord 2014, 29(2):195-202.
16. Chen JJ, Marsh L Anxiety in Parkinson's disease: identification and management. Ther Adv Neurol Disord 2014, 7(1):52-59.
17. NICE Costing statement: 'Depression: the treatment and management of depression in adults (update)' and 'Depression in adults with a chronic physical health problem: treatment and management' [February 2014], Available from:. http://www.nice.org.uk/nicemedia/live/12329/45943/45943.pdf.
18. Price A, Rayner L, Okon-Rocha E, Evans A, Valsraj K, Higginson IJ, et al. Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials. J Neurol Neurosurg Psychiatry 2011, 82(8):914-923.
19. Rocha FL, Murad MG, Stumpf BP, Hara C, Fuzikawa C Antidepressants for depression in Parkinson's disease: systematic review and meta-analysis. J Psychopharmacol 2013, 27(5):417-423.
20. Hind D, Cotter J, Thake A, Bradburn M, Cooper C, Isaac C, et al. Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: A systematic review and meta-analysis. BMC Psychiatry 2014, 14:5.
21. Fiest KM, Dykeman J, Patten SB, Wiebe S, Kaplan GG, Maxwell CJ, et al. Depression in epilepsy a systematic review and meta-analysis. Neurology 2013, 80(6):590-599.
22. Beck AT Cognitive therapy and the emotional disorders 1979, Penguin.
23. Jackson N, Waters E Criteria for the systematic review of health promotion and public health interventions. Health Promot Int 2005, 20(4):367-374.
24. Forman A, Lincoln N Evaluation of an adjustment group for people with multiple sclerosis: a pilot randomized controlled trial. Clin Rehabil 2010, 24(3):211-221.
25. Mohr DC, Likosky W, Bertagnolli A, Goodkin DE, Van Der Wende J, Dwyer P, et al. Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J Consult Clin Psychol 2000, 68(2):356.
26. Gandy M, Sharpe L, Nicholson Perry K, Thayer Z, Miller L, Boserio J, et al. Cognitive Behaviour Therapy to Improve Mood in People with Epilepsy: A Randomised Controlled Trial. Cogn Behav Ther 2014, 43(2):153-166.
27. Lincoln NB, Yuill F, Holmes J, Drummond AE, Constantinescu CS, Armstrong S, et al. Evaluation of an adjustment group for people with multiple sclerosis and low mood: a randomized controlled trial. Mult Scler (Houndmills, Basingstoke, England) 2011, 17(10):1250-1257.
28. Pilutti L, Dlugonski D, Sandroff B, Klaren R, Motl R Randomized controlled trial of a behavioral intervention targeting symptoms and physical activity in multiple sclerosis. Mult Scler 2014, 20(5):594-601.
29. Thompson NJ, Walker ER, Obolensky N, Winning A, Barmon C, DiIorio C, et al. Distance delivery of mindfulness-based cognitive therapy for depression: Project UPLIFT. Epilepsy Behav 2010, 19(3):247-254.
30. Troeung L, Egan SJ, Gasson N A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson's disease. BMC Psychiatry 2014, 14:19.
31. Larcombe NA, Wilson PH An evaluation of cognitive-behaviour therapy for depression in patients with multiple sclerosis. Br J Psychiatry 1984, 145:366-371.
32. Teri L, Logsdon RG, Uomoto J, McCurry SM Behavioral treatment of depression in dementia patients: a controlled clinical trial. J Gerontol B Psychol Sci Soc Sci 1997, 52(4):P159-P166.
33. Beckner V, Howard I, Vella L, Mohr DC Telephone-administered psychotherapy for depression in MS patients: moderating role of social support. J Behav Med 2010, 33(1):47-59.
34. Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 2001, 69(6):942-949.
35. Nordin L, Rorsman I Cognitive behavioural therapy in multiple sclerosis: a randomized controlled pilot study of acceptance and commitment therapy. J Rehabil Med 2012, 44(1):87-90.
36. Rigby SA, Thornton EW, Young CA A randomized group intervention trial to enhance mood and self-efficacy in people with multiple sclerosis. Br J Health Psychol 2008, 13(Pt 4):619-631.
37. Graziano F, Calandri E, Borghi M, Bonino S The effects of a group-based cognitive behavioral therapy on people with multiple sclerosis: a randomized controlled trial. Clin Rehabil 2014, 28(3):264-274.
38. Dobkin RD, Menza M, Allen LA, Gara MA, Mark MH, Tiu J, et al. Cognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized Controlled Trial. Am J Psychiatry 2011, 168(10):1066-1074.
39. Baron KG, Corden M, Jin L, Mohr DC Impact of psychotherapy on insomnia symptoms in patients with depression and multiple sclerosis. J Behav Med 2011, 34(2):92-101.
40. Mohr DC, Hart SL, Julian L, Catledge C, Honos-Webb L, Vella L, et al. Telephone-administered psychotherapy for depression. Arch Gen Psychiatry 2005, 62(9):1007-1014.
41. American Psychiatric Association A, Association AP Diagnostic and statistical manual of mental disorders 1994.
42. Burns A, Guthrie E, Marino-Francis F, Busby C, Morris J, Russell E, et al. Brief psychotherapy in Alzheimer's disease: randomised controlled trial. Br J Psychiatry 2005, 187:143-147.
43. Mohr DC, Ho J, Duffecy J, et al. Effect of telephone-administered vs face-to-face cognitive behavioral therapy on adherence to therapy and depression outcomes among primary care patients: A randomized trial. JAMA 2012, 307(21):2278-2285.